Equate Arnica Pain Relieving
Arnica Montana Whole
Walmart, Inc.
Human Otc Drug
NDC 49035-673Equate Arnica Pain Relieving also known as Arnica Montana Whole is a human otc drug labeled by 'Walmart, Inc.'. National Drug Code (NDC) number for Equate Arnica Pain Relieving is 49035-673. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Equate Arnica Pain Relieving drug includes Arnica Montana Whole - 70 mg/g . The currest status of Equate Arnica Pain Relieving drug is Active.
Drug Information:
| Drug NDC: | 49035-673 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Equate Arnica Pain Relieving |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Arnica Montana Whole |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Walmart, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Gel |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ARNICA MONTANA WHOLE - 70 mg/g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 30 Apr, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 07 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Walmart, Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0687737352406
|
| UPC stands for Universal Product Code. |
| UNII: | O80TY208ZW
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 49035-673-01 | 1 CYLINDER in 1 CARTON (49035-673-01) / 74 g in 1 CYLINDER | 30 Apr, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose** relieve muscle pain and stiffness, swelling from injuries, discoloration from bruises
Product Elements:
Equate arnica pain relieving arnica montana whole arnica montana whole arnica montana whole sodium laureth-3 sulfate capsaicin carbomer homopolymer, unspecified type glycerin sodium hydroxide water
Indications and Usage:
Uses** according to homeopathic principles, the active ingredient in this product temporarily relieves minor symptoms such as: ⦠bruising and swelling ⦠sprains ⦠backaches ⦠muscular aches and pains ⦠strains ⦠stiffness
Warnings:
Warnings for external use only. do not use on damaged skin, open wounds, or mucous membranes. test on a small patch of skin before applying generously. ⦠according to homeopathic principles, symptoms may temporarily worsen before improving (initial exacerbation of symptoms). ⦠avoid contact with eyes. ⦠do not use if you are allergic to arnica montana (asteracea flower) or any of this product's inactive ingredients. ⦠do not bandage tightly or use with a heating pad. ⦠do not use with heating pads or other heating devices. ⦠if conditions worsen or if symptoms persist for more than 72 hours or clear up and occur again within a few days, discontinue use of this product and consult a physician. when using this product ⦠use only as directed ⦠avoid contact with eyes and mucous membranes ⦠if redness is present, discontinue use and consult a doctor ⦠if skin irritation occurs, discontinue use ⦠a transient burning sensation may occur
Read more...upon application but generally disappears in several days. flammable ⦠keep away from fire or flame if pregnant, trying to get pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. if swallowed, get medical help or contact a poison control center immediately.
When Using:
When using this product ⦠use only as directed ⦠avoid contact with eyes and mucous membranes ⦠if redness is present, discontinue use and consult a doctor ⦠if skin irritation occurs, discontinue use ⦠a transient burning sensation may occur upon application but generally disappears in several days.
Dosage and Administration:
Directions for adults and children 2 years of age and older: ⦠apply a thin layer to affected area as soon as possible after minor injury. repeat 3 times a day or as needed.
Package Label Principal Display Panel:
Principal display panel - 74 g cylinder carton ndc 49035-673-01 equate⢠compare to arnicare® gel active ingredient* with capsaicin arnica pain relieving â ** gel homeopathic medicine relieves: â ** muscle pain & stiffness swelling from injuries bruising non-greasy fast-absorbing unscented paraben-free no mess roll-on applicator net wt 2.6 oz (74g) **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. principal display panel - 74 g cylinder carton
Further Questions:
Questions or comments? 1-888-287-1915